Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: JAGX) | Delayed: 2.15 -0.13 (5.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.28 | 52 Week High | $4.60 | |||
| Open | $2.23 | 52 Week Low | $0.81 | |||
| Day High | $2.32 | P/E | N/A | |||
| Day Low | $2.15 | EPS | $0.00 | |||
| Volume | 217,914 | |||||
